Product Design, Manufacturing & Innovation Resources
집 » 우수 의약품 제조 기준(GMP)

우수 의약품 제조 기준(GMP)

1960
우수 의약품 제조 관리 기준(GMP)을 준수하는 제약 제조 시설.

(설명을 위한 생성된 이미지입니다)

Good Manufacturing Practice (GMP) is a system of regulations and guidelines ensuring that pharmaceutical products are consistently produced and controlled according to quality standards. It covers all aspects of production, from the starting materials, premises, and equipment to the training and personal hygiene of staff. GMP is designed to minimize the risks involved in any pharmaceutical production. GMP compliance is demonstrated in practice through IQ OQ PQ process validation of the equipment and processes.

Good Manufacturing Practice (GMP) represents the minimum standard that a medicines manufacturer must meet in their production processes. The core principle of GMP is that quality cannot be tested into a final product; it must be built into the product during all stages of manufacturing. This proactive approach is critical because failures in quality can have life-threatening consequences. GMP guidelines provide a framework for managing production and quality control, often referred to as cGMP, with the ‘c’ standing for ‘current’, emphasizing that the standards must be up-to-date with the latest technology and scientific understanding. Key components of GMP include robust quality management systems, stringent control over raw materials, validated manufacturing processes, and comprehensive documentation. Every step, from receiving raw materials to shipping the final product, must be documented in detail. This creates a traceable batch record that can be audited to ensure compliance and investigate any deviations or product defects. Personnel must be properly trained for their specific roles, and facilities must be designed and maintained to prevent contamination, mix-ups, and errors. Equipment must be calibrated, cleaned, and validated to ensure it performs as intended. Adherence to GMP is enforced by national regulatory agencies, such as the Food and Drug Administration (FDA) in the United States and the European Medicines Agency (EMA) in Europe, through regular inspections of manufacturing facilities. Failure to comply can result in product recalls, fines, and even facility shutdowns.

UNESCO Nomenclature: 3308
– Pharmacy

유형

추상 시스템

분열

상당한

용법

널리 사용됨

전구체

  • the 1938 federal food, drug, and cosmetic act in the US, which mandated pre-market safety approval
  • the Thalidomide tragedy of the late 1950s and early 1960s, which highlighted severe gaps in drug regulation and testing
  • advances in industrial 프로세스 제어 and quality management theories from other industries

응용 프로그램

  • manufacturing of prescription and over-the-counter drugs
  • 생산 백신 and biologics
  • manufacturing of medical devices
  • production of active pharmaceutical ingredients (apis)
  • quality control in the food and cosmetics industries

특허:

NA

잠재적 혁신 아이디어

  • implementation of ‘quality by design’ (QbD) principles for proactive quality management
  • use of process analytical technology (pat) for real-time monitoring of manufacturing
  • continuous manufacturing processes instead of traditional batch production
  • automation and robotics in production lines to reduce human error
  • 블록체인 for secure and transparent supply chain tracking (track and trace)
  • single-use disposable technology to reduce cross-contamination risks
  • ai-driven predictive maintenance for manufacturing equipment
  • digital batch records and electronic quality management systems
  • advanced aseptic processing techniques for sterile products
  • 3d printing of personalized dosage forms under gmp conditions
Related to: GMP, cGMP, quality control, quality assurance, pharmaceutical manufacturing, fda, regulation, drug safety, validation, batch record.

역사적 맥락

우수 의약품 제조 기준(GMP)

1958
1960
1960
1960
1960
1960
1960
1956
1960
1960
1960
1960
1960
1960
1960

(날짜를 알 수 없거나 관련이 없는 경우, 예를 들어 "유체역학"의 경우, 주목할 만한 등장 시기를 대략적으로 추정하여 제공합니다.)

10년차 기념일

고화질 이미지 및 다운로드는 등록된 회원에게만 100% 무료로 제공됩니다.

> 로그인 <